Literature DB >> 11229853

Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients.

S F Dowell1, R L Garman, G Liu, O S Levine, Y H Yang.   

Abstract

In our evaluation of a new assay for the detection of pneumococcal antigen in urine (Binax NOW; Binax), the test result was no more likely to be positive among 88 children with radiographically confirmed pneumonia than among 198 control subjects; however, it was significantly more likely to be positive among children who were nasopharyngeal carriers of pneumococci. This test is not likely to be useful for distinguishing children with pneumococcal pneumonia from those who are merely colonized.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11229853     DOI: 10.1086/319205

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  57 in total

1.  Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children.

Authors:  J Domínguez; S Blanco; C Rodrigo; M Azuara; N Galí; A Mainou; A Esteve; A Castellví; C Prat; L Matas; V Ausina
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Assessment of a commercial rapid urinary antigen test to detect Streptococcus pneumoniae in patients who received 23-valent pneumococcal polysaccharide vaccine.

Authors:  E García Vázquez; M A Marcos; A Vilella; J Yagüe; J M Bayas; J Mensa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

3.  Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients.

Authors:  Samuel Yang; Shin Lin; Ambreen Khalil; Charlotte Gaydos; Eric Nuemberger; George Juan; Justin Hardick; John G Bartlett; Paul G Auwaerter; Richard E Rothman
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 4.  Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections.

Authors:  K Loens; L Van Heirstraeten; S Malhotra-Kumar; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

5.  Breathing new life into pneumonia diagnostics.

Authors:  David R Murdoch; Katherine L O'Brien; J Anthony G Scott; Ruth A Karron; Niranjan Bhat; Amanda J Driscoll; Maria Deloria Knoll; Orin S Levine
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

Review 6.  Pneumonia research to reduce childhood mortality in the developing world.

Authors:  J Anthony G Scott; W Abdullah Brooks; J S Malik Peiris; Douglas Holtzman; E Kim Mulholland
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

7.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

8.  Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection.

Authors:  John P Leeming; Keith Cartwright; Rhonwen Morris; Siobhan A Martin; Michael D Smith
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

9.  Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation.

Authors:  Michael D Smith; Petra Derrington; Rachel Evans; Marjorie Creek; Rhonwen Morris; David A B Dance; Keith Cartwright
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

Review 10.  Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.

Authors:  Matti Korppi
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.